tiprankstipranks
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
US Market
ARVN
Arvinas Holding Company
RESEARCH TOOLSreports
Want to see ARVN full AI Analyst Report?

Arvinas Holding Company (ARVN) Stock News & Sentiment

1,047 Followers
Arvinas Gains First FDA Approval for Breast Cancer Drug
Premium
Company Announcements
Arvinas Gains First FDA Approval for Breast Cancer Drug
23h ago
8K
ARVN
Arvinas Buy Rating Driven by Robust ARV-102 LRRK2 Degrader Data and Clear Neurodegeneration Development Path
Premium
Ratings
Arvinas Buy Rating Driven by Robust ARV-102 LRRK2 Degrader Data and Clear Neurodegeneration Development Path
1M ago
ARVN
Balanced View on Arvinas: Early Promise of ARV-102 Offset by Clinical, Safety, and Competitive Uncertainties Supporting a Hold Rating
Premium
Ratings
Balanced View on Arvinas: Early Promise of ARV-102 Offset by Clinical, Safety, and Competitive Uncertainties Supporting a Hold Rating
1M ago
ARVN
ARV-102 Data Strengthens Neurodegeneration Pipeline Prospects, Supporting Higher $16 Target and Buy Rating on Arvinas
Premium
Ratings
ARV-102 Data Strengthens Neurodegeneration Pipeline Prospects, Supporting Higher $16 Target and Buy Rating on Arvinas
1M ago
ARVN
Arvinas Reports Positive Phase 1 Data for ARV-102
Premium
Company Announcements
Arvinas Reports Positive Phase 1 Data for ARV-102
2M ago
8K
ARVN
Regulatory Turbulence: How FDA Disruptions and Budget Cuts Threaten Arvinas Holding Company’s Drug Development Timelines
Premium
Company Announcements
Regulatory Turbulence: How FDA Disruptions and Budget Cuts Threaten Arvinas Holding Company’s Drug Development Timelines
2M ago
ARVN
Arvinas: Strong Pipeline Momentum, De-Risked Cash Runway, and Attractive Risk‑Reward Support Buy Rating
Premium
Ratings
Arvinas: Strong Pipeline Momentum, De-Risked Cash Runway, and Attractive Risk‑Reward Support Buy Rating
2M ago
ARVN
More ARVN News >

ARVN News on the Web

Analysts Offer Insights on Healthcare Companies: Microbot Medical (MBOT), Arvinas Holding Company (ARVN) and Immuneering (IMRX)
TipRanks News
Bullish
Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?
Zacks
Bullish
Top Executive’s Surprise Stock Move Shakes Up Arvinas Holding Company
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS), High Tide (HITI) and Arvinas Holding Company (ARVN)
TipRanks News
Neutral
Arvinas Buy Rating Driven by Robust ARV-102 LRRK2 Degrader Data and Clear Neurodegeneration Development Path
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), HeartFlow, Inc. (HTFL) and Arvinas Holding Company (ARVN)
TipRanks News
Neutral
Wells Fargo Reaffirms Their Buy Rating on Arvinas Holding Company (ARVN)
TipRanks News
Neutral
Balanced View on Arvinas: Early Promise of ARV-102 Offset by Clinical, Safety, and Competitive Uncertainties Supporting a Hold Rating
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ARVN
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARVN’s Media Buzz Sentiment?
1 articles about ARVN were published this week. In an average week, 3.5 articles are published.
    What is ARVN’s weekly average amount of articles?
    In an average week, 3.5 articles about ARVN are published.
      What is ARVN’s News Sentiment?
      100% of articles about ARVN were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week